Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244745 | SCV000307540 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000295597 | SCV000468121 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000295597 | SCV000624145 | benign | Primary ciliary dyskinesia | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000295597 | SCV002647803 | likely benign | Primary ciliary dyskinesia | 2022-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437042 | SCV004163794 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | DNAH11: BS2 |